Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02177669 · ClinicalTrials.gov registry record

Test-Retest Variability of Quick Contrast Sensitivity Function Testing

A clinical trial, sponsored by Nova Southeastern University.

Completed
Registry status
100
Enrollment target

NCT02177669 is a clinical trial that has completed, run by Nova Southeastern University. The registered enrollment target is 100 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02177669 has completed, sponsored by Nova Southeastern University.

COMPLETED
Registry status
100 participants
Enrollment target

Study Summary

The contrast sensitivity function (CSF) provides a comprehensive characterization of spatial vision and predicts functional vision better than visual acuity, but long testing times prevent its psychophysical assessment in clinical applications. Dr. Luis Lesmes et al. (2010) developed the qCSF method to obtain precise CSF measurements in only 30-50 trials using a computerized software program that presents letters on a large monitor that are identified by a patient similar to typical visual acuity testing with an eye chart. The quick CSF method is a Bayesian adaptive method that estimates the full shape of the CSF, and the test duration is only about 3-6 minutes. Some preliminary testing has been performed at other sites with this test in patients with vision loss due to amblyopia and glaucoma, but data from individuals without eye disease who have normal visual acuity has not been systematically collected with the latest version of this test procedure across a wide range of ages. In addition, we aim to gain a better understanding of the typical test-retest variability that is obtained between-sessions that are about a week apart from individuals with good ocular health and visual acuity.

Interventions

  • OTHER quick Contrast Sensitivity Function test

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2014-06
Est. Completion 2016-11

Sponsor

Nova Southeastern University

71 total trials

What the Registry Record Tells You About NCT02177669

The ClinicalTrials.gov registry entry for NCT02177669 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nova Southeastern University, which has 71 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which quick Contrast Sensitivity Function test is the first listed.

NCT02177669 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02177669 about?

NCT02177669 is a clinical study titled "Test-Retest Variability of Quick Contrast Sensitivity Function Testing". The contrast sensitivity function (CSF) provides a comprehensive characterization of spatial vision and predicts functional vision better than visual acuity, but long testing times prevent its psychophysical assessment in clinical applications. Dr. Luis Lesmes et al. (2010) developed the qCSF method...

What is the current status of trial NCT02177669?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2014-06. Estimated completion is 2016-11.

What interventions are being tested in trial NCT02177669?

The interventions under investigation include: quick Contrast Sensitivity Function test (OTHER).

Who is sponsoring clinical trial NCT02177669?

This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.